Evidence map›Paper›PMID 41199264›Full record

ArticleCardiovascular diabetology2025

Sex differences in the prognostic value of urinary albumin-to-creatinine ratio for coronary artery disease and cardiovascular events in people with type 2 diabetes and normoalbuminuria.

Orlando Siverio-Morales, Ainhoa González-Luis, Carmen Mora-Fernández, Carolina Hernández-Carballo, Alberto Martín-Olivera, Juan F Navarro-González, Javier Donate-Correa

Abstract readComparative Study
In one paragraph

Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Orlando Siverio-Morales *Nephrology Service, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Ainhoa González-Luis *Doctoral and Graduate School, University of La Laguna, San Cristóbal de La Laguna, Tenerife, Spain.
Carmen Mora-FernándezUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 380010, Santa Cruz de Tenerife, Spain. mmorfers@gobiernodecanarias.org.
Carolina Hernández-CarballoUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 380010, Santa Cruz de Tenerife, Spain.
Alberto Martín-OliveraUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 380010, Santa Cruz de Tenerife, Spain.
Juan F Navarro-GonzálezNephrology Service, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain. jnavgon@gobiernodecanarias.org.
Javier Donate-CorreaUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 380010, Santa Cruz de Tenerife, Spain. jdoncor@gobiernodecanarias.org.

Funding

Fundación Canaria Instituto de Investigación Sanitaria de Canarias PIFIISC21/08Instituto de Salud Carlos III PI16/00024Instituto de Salud Carlos III PI21/01037
6 · The paper itself

Abstract

backgroundUrinary albumin excretion is an established marker of cardiovascular (CV) risk in people with type 2 diabetes mellitus (T2DM). However, its prognostic significance within the normoalbuminuric range (< 30 mg/g) remains uncertain, particularly regarding sex-specific differences. This study examined whether urinary albumin-to-creatinine ratio (UACR; KDIGO A1 range) is associated with coronary artery disease (CAD) severity and 6-year major adverse cardiovascular events (MACE) in women and in men with T2DM and preserved kidney function (eGFR > 60 mL/min/1.73 m², UACR < 30 mg/g), treating sex differences as a co-primary objective.

methodsWe conducted a retrospective cohort study involving adults with T2DM who underwent diagnostic coronary angiography. Baseline associations between log-transformed UACR, CAD severity, CV risk factors, and inflammatory markers were evaluated using multivariable linear regression. MACE (defined as non-fatal myocardial infarction or unstable angina requiring urgent revascularization, stroke, or CV death) were recorded during 6-year of follow-up. Cox proportional hazards models, adjusted for age, sex, hypertension, smoking, BMI, lipid profile, hs-CRP, and ACEI/ARB use, were used to assess UACR-MACE associations.

resultsWe included 420 adults (180 women, 42.9%) with a mean of age 65.3 ± 10.7 years and a median UACR 7.56 mg/g (IQR 4.12-15.5). Significant CAD was present in 310 participants (73.8%), and 78 experienced MACE during follow-up (35.5%). Higher UACR was independently associated with greater coronary stenosis (adjusted R² = 0.090, p < 0.001). Kaplan-Meier analysis showed a significantly higher incidence of MACE in the highest UACR tertile (log-rank p = 0.039). In multivariable Cox models adjusted for age, sex, hypertension, smoking, lipid profile, hs-CRP, SSI, and ACEI/ARB use, higher log-UACR independently predicted MACE (adjusted HR 1.67, 95% CI 1.35-2.10; p < 0.01). In sex-stratified Cox models, higher log-UACR predicted MACE in both sexes and remained independently associated in multivariable analyses (adjusted HR 1.67, 95% CI 1.35-2.10; p < 0.01). Associations were directionally stronger in women, who showed higher cumulative event rates across UACR tertiles, although the formal UACR × sex interaction did not reach statistical significance.

conclusionsWithin the normoalbuminuric range, UACR is associated with greater CAD burden and higher 6-year MACE risk, with sex-specific differences. These findings suggest potential sex-related variation in the prognostic value of high-normal albuminuria, particularly among women, warranting validation in larger and more diverse cohorts.

Indexed as

AlbuminuriaCoronary Artery DiseaseCreatinineDiabetes Mellitus, Type 2AgedBiomarkersCoronary AngiographyFemaleHumansMaleMiddle AgedPredictive Value of TestsPrognosisProportional Hazards ModelsRetrospective StudiesRisk FactorsBiomarkersCreatinineCoronary artery diseaseMajor adverse cardiovascular eventsNormoalbuminuriaSexType 2 diabetes mellitus

Identifiers

PMID41199264
PMCPMC12590722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.